VeriMomБезопасен ли hexapeptide-12 при беременности?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
Pregnancy-safe products containing hexapeptide-12
Related ingredients
Frequently asked questions
- Безопасен ли hexapeptide-12 при беременности?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment for 'hexapeptide-12' was identified, and no PubMed reproductive or developmental toxicity studies for this ingredient were found in the available literature. Per CIR/SCCS default approach, absence of reproductive hazard data and absence of harmonised flags supports a default score of 0 for hazard and mechanism; expected dermal absorption for a short peptide is very low so exposure from topical cosmetic use is assessed as negligible. Sources consulted: ECHA Annex VI (no listing), SCCS/CIR (no opinion found), PubMed (no reproductive/developmental studies found), CosIng/PubChem (no hazard classification).
- Безопасен ли hexapeptide-12 при грудном вскармливании?
- No data indicating reproductive or lactation toxicity, no mechanistic evidence for transfer into breastmilk, and no harmonised classifications. With no demonstrated systemic bioavailability from topical use, breastfeeding exposure is considered negligible. Sources: SCCS/CIR (no opinion), PubMed (no lactation studies), PubChem/CosIng (no hazard data).
- Безопасен ли hexapeptide-12 для кожи малыша?
- No infant-specific toxicity or developmental data identified. Hazard and mechanism remain 0 due to lack of evidence or harmonised classification. Dermal exposure score increased by +1 for baby skin (to 1) because peptides are not completely non‑absorbable and infant skin has a higher surface-area-to-weight ratio and immature barrier, so a low but measurable exposure is plausible even if adult absorption is negligible. Sources: general dermal absorption principles (peptide physicochemistry), CosIng/PubChem (ingredient listings), PubMed (no infant studies).
- Как VeriMom оценивает hexapeptide-12?
- VeriMom оценивает hexapeptide-12 в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы hexapeptide-12 при беременности?
- См. наш список безопасных альтернатив hexapeptide-12 с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.